Skip to main content

research

Assessment of cancer biomarkers in the Grenfell firefighter cohort study

Article
Using next-generation sequencing and a panel that detects pathogenic DNA variants linked to various cancers, we analysed a subset of 261 firefighters. Our findings revealed that 11 firefighters carried pathogenic DNA variants associated with cancer, but we found no association between fire smoke exposure and the presence of these variants.

Patterns of mouse allergen–specific IgE and IgG4 in contemporary animal research environments

Article

Laboratory animal allergy (LAA) results from occupational ex-posure to allergens found in the hair, dander, urine, and salivaof laboratory animals. It presents as work-related rhinocon-junctivitis and occupational asthma after a latency period of2–3 years. Prevalence of rodent-sensitisation among laboratoryanimal (LA) workers ranges between 10.4% [1] and 28% [2].Though exposure is a major risk factor, some individuals developallergen-specific IgE without progressing to LAA symptoms andare considered clinically tolerant [3].

UK Silicosis Registry

Image
UK Silicosis Registry

In 2026, we set up the UK Silicosis Registry (UK SR) supported by funding from the RBHH Charity. The UK SR is based at Imperial College London. 

A Registry is like a survey that collects health information about people with a specific medical condition. In the UK SR, these are people with silicosis who have developed the condition from exposure to silica dust in their jobs. Bringing together information on people across the UK means we can better understand silicosis and how best to treat it. We can also compare patients with silicosis in the UK with those in other countries. 

This is an observational study, which means we are not testing any new treatments but instead collect information about work histories, medical histories and test results recorded during usual clinic visits with your respiratory clinical teams. The data is pseudo-anonymised so that individuals cannot be identified. 

At the moment, only patients seen in the Royal Brompton Hospital Occupational Lung Disease clinic are able to take part but the plan is to expand this to other services around the UK in the near future. 

For further information on the study, please contact the chief investigator Dr Johanna Feary (j.feary@imperial.ac.uk).